Lishan Aklog - Net Worth and Insider Trading
Lishan Aklog Net Worth
The estimated net worth of Lishan Aklog is at least $284,791 dollars as of 2024-12-13. Lishan Aklog is the Chairman and CEO, 10% Owner of PAVmed Inc and owns about 372,471 shares of PAVmed Inc (PAVM) stock worth over $284,791. Details can be seen in Lishan Aklog's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lishan Aklog has not made any transactions after 2021-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lishan Aklog
Lishan Aklog Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lishan Aklog owns 5 companies in total, including ContraFect Corp (CFRXQ) , PAVmed Inc (PAVM) , and Lucid Diagnostics Inc (LUCD) among others .
Click here to see the complete history of Lishan Aklog’s form 4 insider trades.
Insider Ownership Summary of Lishan Aklog
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CFRXQ | ContraFect Corp | 2020-06-15 | director |
PAVM | PAVmed Inc | 2022-02-18 | director & 10 percent owner & Chairman and CEO |
LUCD | Lucid Diagnostics Inc | 2021-10-13 | director & Chief Executive Officer |
2020-12-22 | director | ||
2020-12-22 | director |
Lishan Aklog Latest Holdings Summary
Lishan Aklog currently owns a total of 1 stock. Lishan Aklog owns 372,471 shares of PAVmed Inc (PAVM) as of March 18, 2021, with a value of $284,791.
Latest Holdings of Lishan Aklog
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PAVM | PAVmed Inc | 2021-03-18 | 372,471 | 0.76 | 284,791 |
Holding Weightings of Lishan Aklog
Lishan Aklog Form 4 Trading Tracker
According to the SEC Form 4 filings, Lishan Aklog has made a total of 1 transactions in PAVmed Inc (PAVM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PAVmed Inc is the acquisition of 500 shares on March 18, 2021, which cost Lishan Aklog around $32,325.
Insider Trading History of Lishan Aklog
- 1
Lishan Aklog Trading Performance
GuruFocus tracks the stock performance after each of Lishan Aklog's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lishan Aklog is -23.78%. GuruFocus also compares Lishan Aklog's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lishan Aklog within 3 months outperforms 2 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lishan Aklog's insider trading performs compared to the benchmark.
Performance of Lishan Aklog
Lishan Aklog Ownership Network
Ownership Network List of Lishan Aklog
Ownership Network Relation of Lishan Aklog
Lishan Aklog Owned Company Details
What does ContraFect Corp do?
Who are the key executives at ContraFect Corp?
Lishan Aklog is the director of ContraFect Corp. Other key executives at ContraFect Corp include VP Finance Michael Messinger , General Counsel Natalie Bogdanos , and Chief Medical Officer Cara M Cassino .
ContraFect Corp (CFRXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ContraFect Corp (CFRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ContraFect Corp (CFRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ContraFect Corp (CFRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
ContraFect Corp Insider Transactions
Lishan Aklog Mailing Address
Above is the net worth, insider trading, and ownership report for Lishan Aklog. You might contact Lishan Aklog via mailing address: 420 Lexington Avenue, Suite 300, New York Ny 10171.